Lilly resubmits application for Cymbalta - MarketWatch

Links shared publicly online about this topic.

1,996
total visits

Lilly resubmits application for Cymbalta - MarketWatch

BOSTON (MarketWatch) -- Eli Lilly & Co. said Wednesday that it has resubmitted its application to have its antidepressant Cymbalta approved to also treat chronic pain. Cymbalta is already approved in the U.S. to treat major depression, generalized anxiety disorder, and pain associated with fibromyalgia and diabetic neuropathy. Lilly originally applied to have the product approved for chronic pain in the second quarter 2008, but later withdrew the application after regulators questioned the d

View full resource at marketwatch.com

Tags: Antidepressant, Major Depression, Fibromyalgia, Fibromyalgia Medication, Neuropathic Pain Medication, Disease and Condition, Cymbalta, Eli Lilly and Company

Most Recently Shared on June 3, 2009 at 6:55 pm By:

Gina Selir

Lilly resubmits application for Cymbalta - MarketWatch http://tinyurl.com/ql29ku

3 years ago...

Retweet

Favorite

FDA Panel Supports Cymbalta for Chronic Pain

webmd.com — “An FDA advisory panel gave a closely divided vote of support to drugmaker Eli Lilly's application to increase the number of approved uses for one of its best-selling drugs, the antidepressant Cymbalta.” View full resource at webmd.com

Most Recently Shared on August 20, 2010 at 12:19 am By:

Heart Health Health News

webMD: FDA Panel Supports Cymbalta for Chronic Pain http://bit.ly/9bfyNN Full http://bit.ly/cwUeLw

2 years ago...

Retweet

Favorite

Federal drug regulators cautious about expanding use of Eli Lilly's antidepressant Cymbalta | NJ.com

nj.com — “Eli Lilly has been trying to gain approval for pain more than two years. The company withdrew its FDA application in November 2008 after agency evaluators questioned the method and design of some of the company's trials. The drug is already approved to treat depression, diabetic nerve pain and fibromyalgia.” View full resource at nj.com

Most Recently Shared on August 17, 2010 at 10:58 pm By:

Fibromyalgia OW OW Health

Federal drug regulators cautious about expanding use of Eli Lilly's antidepressant Cymbalta: Eli Lilly has been tr... http://bit.ly/9b9cv4

2 years ago...

Retweet

Favorite

Eli Lilly and Company - Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

newsroom.lilly.com — “Eli Lilly and Company - Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration” View full resource at newsroom.lilly.com